ArticleBMC musculoskeletal disorders2025
Arthroscopic PRP gel augmentation at the tendon-bone interface accelerates functional recovery and structural healing in rotator cuff repair: a retrospective cohort study.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biologic augmentation in rotator cuff repair: current evidence and future directions.JSES reviews, reports, and techniques · 2026Review
- A comparative study of the clinical value of PRP and microfracture techniques in the repair of rotator cuff injuries.Journal of orthopaedic surgery and research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study aimed to evaluate whether intraoperative application of platelet-rich plasma (PRP) gel at the tendon-bone interface during arthroscopic rotator cuff repair enhances functional recovery, reduces pain, and improves tendon healing within the critical 6-month postoperative window-a pivotal period for retear risk, socioeconomic reintegration, and ERAS (Enhanced Recovery After Surgery) outcomes.
methodsIn this retrospective cohort study, 152 patients with full-thickness supraspinatus tears underwent arthroscopic repair. The PRP group (n = 91) received thrombin-activated PRP gel injected at the tendon-bone interface under direct arthroscopic visualization, while controls (n = 61) received standard repair alone. Functional outcomes (Constant-Murley Score [CMS], American Shoulder and Elbow Surgeons [ASES] score, Subjective Shoulder Value [SSV]) and pain (Visual Analog Scale [VAS]) were assessed preoperatively and at 6 months postoperatively. Tendon healing was evaluated via MRI using Sugaya classification and tendon thickness measurement.
resultsAt 6 months postoperatively, the PRP group demonstrated significantly greater improvements in all outcomes versus controls: Functional recovery: ΔCMS = 23.33 vs. 13.08 (p < 0.01); ΔASES = 45.56 vs. 38.78 (p < 0.01); SSV = 82.97% vs. 78.85% (p = 0.006); Pain reduction: ΔVAS = 3.97 vs. 3.51 (p < 0.01); Tendon healing: Sugaya grade distribution significantly favored the PRP group (p < 0.001), with 89.0% vs. 54.1% achieving favorable healing (I/II) and lower retear rates (IV/V: 2.2% vs. 13.1%); tendon thickness 0.63 ± 0.08 cm vs. 0.50 ± 0.06 cm (p < 0.001).
conclusionPRP gel application was associated significantly greater improvement in functional recovery, greater reduction in pain, and better structural healing at 6 months postoperatively. This approach may support the objectives of enhanced recovery pathways by potentially facilitating a timely return to productivity and reducing socioeconomic burdens, supporting its role as a cost-effective adjunct to rotator cuff repair.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.